The Role of Anti–Endothelial Cell Antibody–Mediated Microvascular Injury in the Evolution of Pulmonary Fibrosis in the Setting of Collagen Vascular Disease-Reference-Cited by-同舟云学术

The Role of Anti–Endothelial Cell Antibody–Mediated Microvascular Injury in the Evolution of Pulmonary Fibrosis in the Setting of Collagen Vascular Disease

Published:2007-02 Issue:2 Volume:127 Page:237-247
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Magro Cynthia M.,Marsh Clay B.,Allen James N.,Ross Patrick,Liff David,Knight Deborah A.,Waldman W. James,Nadasdy Tibor,Cowden Daniel J.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/127/2/237/4988229/ajcpath127-0237.pdf

Reference44 articles.

1. Du Bois RM, Wells AU. The lung in rheumatic diseases. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds.Rheumatology. 3rd ed. Philadelphia, PA: Mosby; 2003; 315-324.

2. Nylander Lundqvist E, Back O, Nilsson TK, et al. Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol. 1992; 11:248-253.

3. Magro CM, Ross P, Pope-Harman A, et al. Direct and indirect immunofluorescence as a diagnostic adjunct to the interpretation of nonneoplastic lung disease. Am J Clin Pathol. 2003; 119:279-289.

4. Wusirika R, Ferri C, Marin M, et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. Am J Clin Pathol. 2003; 120:596-606.

5. Hedgpeth MT, Bouware DW. Interstitial pneumonitis in antinuclear antibody—negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthiritis Rheum. 1988; 31:545-548.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody;Arthritis Research & Therapy;2023-07-24

2. Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies;Frontiers in Immunology;2022-05-06

3. Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis;Journal of Personalized Medicine;2022-02-15

4. Etiology and pathogenesis of auditory and vestibular dysfunction in patients with autoimmune disorders;Translational Autoimmunity;2022

5. Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial;Respiratory Medicine and Research;2020-11